US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 9.695
  • -0.555-5.41%
Trading Apr 18 15:13 ET
1.09BMarket Cap-2564P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
1,517.09%59.61M
356.81%13.53M
5,156.41%38.11M
5.19M
2.78M
3.69M
2.96M
725K
0
0
Operating revenue
691.81%29.19M
356.81%13.53M
1,018.48%8.11M
--4.77M
--2.78M
--3.69M
--2.96M
--725K
--0
--0
Cost of revenue
561.41%4.99M
363.09%2.25M
339.41%1.18M
776K
783K
754K
485K
269K
0
0
Gross profit
1,762.86%54.62M
355.57%11.28M
7,998.03%36.93M
4.41M
2M
2.93M
2.48M
456K
0
0
Operating expense
-2.90%295.72M
2.18%72.45M
-29.82%73.83M
8.13%71.18M
24.96%78.26M
47.47%304.56M
-0.54%70.9M
84.32%105.2M
56.43%65.83M
73.56%62.63M
Selling and administrative expenses
51.60%185.15M
31.47%48.67M
34.17%47.6M
66.38%45.96M
95.03%42.92M
100.30%122.12M
97.69%37.02M
115.33%35.47M
144.12%27.62M
52.25%22.01M
Research and development costs
-39.39%110.58M
-29.82%23.78M
-62.38%26.24M
-33.99%25.22M
-12.99%35.35M
25.33%182.44M
-35.54%33.88M
71.73%69.73M
24.18%38.21M
87.80%40.62M
Operating profit
20.07%-241.1M
10.60%-61.17M
64.77%-36.9M
-1.42%-66.76M
-21.77%-76.27M
-46.05%-301.63M
4.01%-68.42M
-83.52%-104.75M
-56.43%-65.83M
-73.56%-62.63M
Net non-operating interest income expense
-89.83%-29.71M
-12.25%-7.76M
-54.30%-7.56M
-267.45%-7.35M
-283.13%-7.04M
-15.65M
-6.92M
-4.9M
-2M
-1.84M
Non-operating interest expense
89.83%29.71M
12.25%7.76M
54.30%7.56M
267.45%7.35M
283.13%7.04M
--15.65M
--6.92M
--4.9M
--2M
--1.84M
Other net income (expense)
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
1,877.55%1.94M
484.72%421K
230.23%142K
Other non- operating income (expenses)
102.47%11.79M
-19.52%2.67M
40.40%2.72M
641.33%3.12M
2,158.45%3.21M
3,264.74%5.82M
8,400.00%3.32M
1,877.55%1.94M
484.72%421K
230.23%142K
Income before tax
16.83%-259.03M
8.00%-66.26M
61.25%-41.74M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
Income tax
3.11M
25K
3.02M
0
0
0
Net income
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
Net income continuous Operations
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
Minority interest income
Net income attributable to the parent company
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.83%-262.14M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.1M
-50.93%-311.46M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
Basic earnings per share
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
-65.79%-1.89
-55.95%-1.31
-67.11%-1.27
Diluted earnings per share
33.22%-3.78
38.98%-0.72
61.38%-0.73
11.45%-1.16
-3.15%-1.31
-35.41%-5.66
16.90%-1.18
-65.79%-1.89
-55.95%-1.31
-67.11%-1.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 1,517.09%59.61M356.81%13.53M5,156.41%38.11M5.19M2.78M3.69M2.96M725K00
Operating revenue 691.81%29.19M356.81%13.53M1,018.48%8.11M--4.77M--2.78M--3.69M--2.96M--725K--0--0
Cost of revenue 561.41%4.99M363.09%2.25M339.41%1.18M776K783K754K485K269K00
Gross profit 1,762.86%54.62M355.57%11.28M7,998.03%36.93M4.41M2M2.93M2.48M456K00
Operating expense -2.90%295.72M2.18%72.45M-29.82%73.83M8.13%71.18M24.96%78.26M47.47%304.56M-0.54%70.9M84.32%105.2M56.43%65.83M73.56%62.63M
Selling and administrative expenses 51.60%185.15M31.47%48.67M34.17%47.6M66.38%45.96M95.03%42.92M100.30%122.12M97.69%37.02M115.33%35.47M144.12%27.62M52.25%22.01M
Research and development costs -39.39%110.58M-29.82%23.78M-62.38%26.24M-33.99%25.22M-12.99%35.35M25.33%182.44M-35.54%33.88M71.73%69.73M24.18%38.21M87.80%40.62M
Operating profit 20.07%-241.1M10.60%-61.17M64.77%-36.9M-1.42%-66.76M-21.77%-76.27M-46.05%-301.63M4.01%-68.42M-83.52%-104.75M-56.43%-65.83M-73.56%-62.63M
Net non-operating interest income expense -89.83%-29.71M-12.25%-7.76M-54.30%-7.56M-267.45%-7.35M-283.13%-7.04M-15.65M-6.92M-4.9M-2M-1.84M
Non-operating interest expense 89.83%29.71M12.25%7.76M54.30%7.56M267.45%7.35M283.13%7.04M--15.65M--6.92M--4.9M--2M--1.84M
Other net income (expense) 102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M1,877.55%1.94M484.72%421K230.23%142K
Other non- operating income (expenses) 102.47%11.79M-19.52%2.67M40.40%2.72M641.33%3.12M2,158.45%3.21M3,264.74%5.82M8,400.00%3.32M1,877.55%1.94M484.72%421K230.23%142K
Income before tax 16.83%-259.03M8.00%-66.26M61.25%-41.74M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M-60.46%-67.41M-78.47%-64.32M
Income tax 3.11M25K3.02M000
Net income 15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M-60.46%-67.41M-78.47%-64.32M
Net income continuous Operations 15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M-60.46%-67.41M-78.47%-64.32M
Minority interest income
Net income attributable to the parent company 15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M-60.46%-67.41M-78.47%-64.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.83%-262.14M7.96%-66.28M58.44%-44.77M-5.32%-70.99M-24.53%-80.1M-50.93%-311.46M-0.97%-72.02M-89.03%-107.71M-60.46%-67.41M-78.47%-64.32M
Basic earnings per share 33.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18-65.79%-1.89-55.95%-1.31-67.11%-1.27
Diluted earnings per share 33.22%-3.7838.98%-0.7261.38%-0.7311.45%-1.16-3.15%-1.31-35.41%-5.6616.90%-1.18-65.79%-1.89-55.95%-1.31-67.11%-1.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg